Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIGLUSTAT vs ELOTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIGLUSTAT vs ELOTUZUMAB: Safety Overview

Metric ELIGLUSTAT ELOTUZUMAB
Total FAERS Reports 1,368 3,440
Deaths Reported 18 676
Death Rate 1.3% 19.7%
Hospitalizations 173 1,499
Average Patient Age 48.6 yrs 67.6 yrs
% Female Patients 57.1% 41.0%
FDA Approval Date Aug 17, 2022 N/A
Manufacturer Genzyme Corporation E.R. Squibb & Sons, L.L.C.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription